checkAd

Evotec Enters Drug Discovery Collaboration with Janssen

(PLX AI) – Evotec enters a drug discovery collaboration with Janssen.Evotec says TargetAlloMod platforms will be evaluated to discover first-in-class novel mode of action therapeutic candidates

  • (PLX AI) – Evotec enters a drug discovery collaboration with Janssen.
  • Evotec says TargetAlloMod platforms will be evaluated to discover first-in-class novel mode of action therapeutic candidates

So handeln Sie das Kursziel

Der Analyst erwartet ein Kursziel von 28,32€, was eine Steigerung von +5,35% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.
Übernehmen
Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
Bitte verändern Sie Kursziel, Zeitraum oder Emittent.Alternativ können Sie auch unsere Derivate-Suchen verwenden
Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche
WerbungDisclaimer
Wertpapier


0 Kommentare
Autor: PLX AI
 |  167   |  0   |   

Schreibe Deinen Kommentar

Disclaimer

Evotec Enters Drug Discovery Collaboration with Janssen (PLX AI) – Evotec enters a drug discovery collaboration with Janssen.Evotec says TargetAlloMod platforms will be evaluated to discover first-in-class novel mode of action therapeutic candidates

Nachrichten des Autors
Plug Power Q2 Revenue Below Expectations; Guidance Unchanged
1064 Leser
BioNTech Q2 Earnings Below Estimates; FY Guidance Unchanged
536 Leser
Ørsted Raises Outlook on Higher Bioenergy & Onshore Earnings
321 Leser
NVIDIA Reports Much Lower Q2 Revenue, Margins Than Previously Forecast
307 Leser
Nel Q2 Revenue Below Expectations; EBITDA Loss Rises
241 Leser
Varta Half Year Adjusted EBITDA EUR 68.9 Million vs. Estimate EUR 76 Million
222 Leser
Micron Technology Says Q4 Revenue May Come In Below Low End of Guidance Range
220 Leser
Illumina Q2 Revenue Below Expectations; Sees 4-5% Growth for Full Year
208 Leser
Hexagon Purus Q2 Revenue Beats Expectations, but EBITDA Loss Higher Than Consensus
200 Leser
Bilfinger Q2 Earnings in Line with Expectations; Outlook Unchanged
182 Leser
Plug Power Q2 Revenue Below Expectations; Guidance Unchanged
1064 Leser
3M to Spin Off Health Care Business by End of 2023
638 Leser
Lundin Energy Q2 Net Income USD 29.5 Million
606 Leser
Intuitive Surgical Q2 Earnings Below Consensus as Covid Remains a Factor
588 Leser
Block Q2 Adjusted EBITDA Beats Expectations; Revenue in Line
557 Leser
BioNTech Q2 Earnings Below Estimates; FY Guidance Unchanged
536 Leser
Deutsche Bank Q2 Net Income, Revenue Above Estimates
401 Leser
Meyer Burger Cuts Production Outlook as Ramp-Up Delayed by Supply Chain Constraints
384 Leser
Infineon Q3 Revenue EUR 3,618 Million vs. Estimate EUR 3,500 Million
380 Leser
Bayer Raises Outlook After Q2 Revenue Beats Expectations
359 Leser
Stillfront buys Jawaker for USD 205 Million in Cash and Shares; to Issue New Shares for SEK 1 ...
3269 Leser
Nokia Reinstated with Neutral Rating at Bank of America
3263 Leser
AkzoNobel Buys Kansai Paint's African Business
2606 Leser
Dentsply Sirona Fired CEO Casey; Board Member Groetelaars Takes Over Temporarily
1562 Leser
Viatris Sells Biosimilars Portfolio to Biocon Biologics for up to $3.335 Bilion
1403 Leser
Nordex Rises as Bank of America Sees Strong Orders in Q3
1348 Leser
Biomerieux Buys Specific Diagnostics for Price Equivalent to 3.3% of Market Cap
1340 Leser
Rexel Buys Mayer for Enterprise Value $456 Million
1336 Leser
Plug Power Q4 Revenue Beats Expectations; Sees Fuel Margins Breakeven by 2023
1206 Leser
Amazon Jumps 7% After Earnings; Takes $11.8 Billion Gain from Rivian
1095 Leser